Remove tag boston-scientific
article thumbnail

A history of Johnson & Johnson

pharmaphorum

Beginning in 2003, J&J became involved in a series of litigations with Boston Scientific involving patents covering heart stent medical devices. The litigation was settled in 2009, when Boston Scientific agreed to pay $716 million in September and an additional $1.73 billion the following February.

Sales 124
article thumbnail

Connecting lab automation to decision-making

Drug Discovery World

Future breakthroughs For us to continue on this upwards trajectory, Pillai says that scientific advancements will and must keep occurring as they are absolutely required to continue progressive work. How can you track and tag information so that when someone looks at it a week later or three years later, the data still makes sense?”